Literature DB >> 3989643

Medical management of congenital nasolacrimal duct obstruction.

T O Paul.   

Abstract

Fifty-five infants were diagnosed to have nasolacrimal duct obstruction by an ophthalmologist prior to three months of age. All were followed prospectively, primarily with medical management. Seven were treated surgically. In the 55 infants, there were 62 obstructed nasolacrimal ducts. Eighty-nine percent (55/62) of the nasolacrimal ducts were opened with medical management only in the first sixteen months of life. Of the nasolacrimal ducts that opened spontaneously, 15% (8/55) were open at three months, 45% (25/55) were open at six months, 71% (39/55) were open at nine months, and 93% (51/55) were open at one year. Based on this data one can advise the parents of infants with nasolacrimal duction what the odds of remission are without surgery by the twelfth month of age. Of the infants obstructed at three months of age, 80% were clear by the twelfth month. Of the infants obstructed at six months, 70% were clear by the twelfth month and of those still obstructed at nine months, 52% were clear by the twelfth month.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3989643     DOI: 10.3928/0191-3913-19850301-09

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  22 in total

1.  Value of nasal endoscopy and probing in the diagnosis and management of children with congenital epiphora.

Authors:  C J MacEwen; J D Young; C W Barras; B Ram; P S White
Journal:  Br J Ophthalmol       Date:  2001-03       Impact factor: 4.638

2.  Long-term results of probing guided with soft cannula in children with congenital nasolacrimal duct obstruction.

Authors:  Dilek Yuksel; Pınar Altiaylik Ozer
Journal:  Jpn J Ophthalmol       Date:  2013-11-16       Impact factor: 2.447

Review 3.  Probing for congenital nasolacrimal duct obstruction.

Authors:  Carisa Petris; Don Liu
Journal:  Cochrane Database Syst Rev       Date:  2017-07-12

4.  Resolution of congenital nasolacrimal duct obstruction with nonsurgical management.

Authors: 
Journal:  Arch Ophthalmol       Date:  2012-06

5.  Otolaryngological findings in congenital nasolacrimal duct obstruction and implications for prognosis.

Authors:  S H Uğurbaş; G Zilelioğlu; M Saatçi
Journal:  Br J Ophthalmol       Date:  2000-08       Impact factor: 4.638

6.  The course of epiphora after failure of silicone intubation for congenital nasolacrimal duct obstruction.

Authors:  Yanir Kassif; Uri Rehany; Michal David; Anna Popko; Shimon Rumelt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-03-09       Impact factor: 3.117

7.  A randomized trial comparing the cost-effectiveness of 2 approaches for treating unilateral nasolacrimal duct obstruction.

Authors: 
Journal:  Arch Ophthalmol       Date:  2012-12

8.  The rate of symptomatic improvement of congenital nasolacrimal duct obstruction in Japanese infants treated with conservative management during the 1st year of age.

Authors:  Hirohiko Kakizaki; Yasuhiro Takahashi; Shinsuke Kinoshita; Kunihiko Shiraki; Masayoshi Iwaki
Journal:  Clin Ophthalmol       Date:  2008-06

9.  Primary treatment of nasolacrimal duct obstruction with balloon catheter dilation in children younger than 4 years of age.

Authors:  Michael X Repka; B Michele Melia; Roy W Beck; Danielle L Chandler; Deborah R Fishman; Todd A Goldblum; Jonathan M Holmes; Bernard D Perla; Graham E Quinn; David I Silbert; David K Wallace
Journal:  J AAPOS       Date:  2008-10       Impact factor: 1.220

10.  Value of microbiology study in congenital nasolacrimal duct obstruction.

Authors:  Yasser H Al-Faky; Tahir Naeem; Nora Al-Sobaie; Reem Al-Huthail; Hessa Al-Odan; Essam A Osman; Ahmad Mousa
Journal:  Saudi J Ophthalmol       Date:  2012-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.